Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheu- matic etiology. J Am Coll Cardiol. 2003;41:1316 24. hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replace- ment in chronic aortic insufficiency. Am J Cardiol. 1982;49:1091 100. 23. Fioretti P, Roelandt J, Bos RJ, et al. Echocardiography in chronic aortic in- sufficiency. Is valve replacement too late when left ventricular end-systolic dimension reaches 55 mm? Circulation. 1983;67:216 21. 24. Stone PH, Clark RD, Goldschlager N, et al. Determinants of prognosis of patients with aortic regurgitation who undergo aortic valve replacement. J Am Coll Cardiol. 1984;3:1118 26. 25. Zhang Z, Yang J, Yu Y, et al. Preoperative ejection fraction determines early recovery of left ventricular end-diastolic dimension after aortic valve replacement for chronic severe aortic regurgitation. J Surg Res. 2015;196:49 55. 26. Murashita T, Schaff HV, Suri RM, et al. Impact of left ventricular systolic function on outcome of correction of chronic severe aortic valve regurgi- tation: implications for timing of surgical intervention. Ann Thorac Surg. 2017;103:1222 8. 27. Wang Y, Jiang W, Liu J, et al. Early surgery versus conventional treatment for asymptomatic severe aortic regurgitation with normal ejection fraction and left ventricular dilatation. Eur J Cardiothorac Surg. 2017;52:118 24. 28. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptom- atic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med. 1994;331:689 94. 29. Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and efficacy of transcath- eter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an Interna- tional Registry Study. JACC Cardiovasc Interv. 2017;10:1048 56. 30. 